Manipal Health IPO Opens Today: Should You Subscribe? Price Band, GMP, Key Dates, Risk & All You Need To Know

The initial public offering (IPO) of Manipal Health Enterprises Ltd opened for public subscription on Tuesday, July 29, 2026. The hospital operator is looking to raise Rs 9,275 crore through a book-built issue, making it one of the largest healthcare IPOs in recent years.

Manipal Health IPO Opens Today: Subscribe or Not; Key Details Investors Should Know

The Manipal Health IPO will remain open for subscription from July 29 to July 31, 2026. The company has fixed the price band at Rs 560-590 per share, while investors can bid for a minimum of 25 equity shares and in multiples thereafter.

At the upper price band, retail investors will require a minimum investment of Rs 14,750, while the maximum application under the retail category stands at 13 lots (325 shares), amounting to Rs 1,91,750. The company is expected to finalise the basis of allotment on August 3, while refunds and credit of shares into demat accounts are scheduled for August 4. The stock is likely to list on both the BSE and NSE on August 5, 2026.

The IPO has reserved 75% of the issue for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (NIIs), and 10% for retail investors. KFin Technologies is the registrar to the issue, while Kotak Mahindra Capital, Axis Capital, Goldman Sachs India, Jefferies India, JP Morgan India, UBS Securities India and DBS Bank India are managing the public offer.

About Manipal Health: India's Largest Private Hospital Network by Bed Capacity

Manipal Health Enterprises operates one of India's largest multi-speciality hospital networks. As of March 31, 2026, the company had 49 hospitals with 13,037 licensed beds spread across 14 states and Union Territories, making it the country's largest private hospital chain by bed capacity. It also ranked second in terms of the number of hospitals among listed private healthcare operators.

The company has built a strong presence in Karnataka, Maharashtra, Goa and eastern India, while also becoming the only private hospital operator to lead Bengaluru, Kolkata and Pune in terms of licensed bed capacity. Nearly 47% of its beds are located in metro cities, with the remaining network spread across non-metro markets, providing geographical diversification and wider patient reach.

Manipal Health Financial Performance

The company's financial performance reflects strong business expansion over the past three years. Revenue from operations increased from Rs 6,171.63 crore in FY24 to Rs 8,242.25 crore in FY25, before rising further to Rs 10,335.75 crore in FY26, highlighting healthy growth driven by capacity additions, acquisitions and higher patient volumes.

Operating performance also remained robust. EBITDA improved from Rs 1,776.60 crore in FY24 to Rs 2,247.07 crore in FY25, reaching Rs 2,795.94 crore in FY26. Although EBITDA margins moderated slightly over the three-year period, they remained comfortably above 27%, reflecting operational efficiency despite expansion.

Profit after tax stood at Rs 916.52 crore in FY26, compared with Rs 1,081.67 crore in FY25 and Rs 533.20 crore in FY24. While profits moderated year-on-year, the company continued to generate healthy operating cash flows, with cash generated from operations rising to Rs 2,078.40 crore during FY26.

One area investors should monitor is debt. Total borrowings increased sharply to over Rs 10,553 crore in FY26 following acquisitions and expansion, making debt reduction one of the key objectives of the IPO.

Key Risks Investors Should Not Ignore

Despite its leadership position, the company faces several risks that investors should evaluate carefully.

Nearly 46% of FY26 revenue was generated from Karnataka, making earnings relatively dependent on one geography. Any regulatory changes, pricing controls or operational disruptions in the state could materially affect business performance.

The company also derives a significant share of inpatient revenue from a handful of speciality segments such as cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and renal sciences. Any slowdown in these high-value treatments may affect revenue growth.

Like all hospital operators, Manipal Health remains exposed to regulatory changes, medical negligence claims, talent retention challenges and healthcare compliance risks. The company also carries relatively high debt following multiple acquisitions, although part of the IPO proceeds will be used to reduce borrowings.

Should You Subscribe Manipal Health IPO?

Domestic brokerage Master Capital Services Ltd has assigned an "Invest Now" rating to the Manipal Health IPO, citing the company's leadership position in India's organised healthcare sector, robust hospital network and favourable long-term industry outlook.

The brokerage believes Manipal Health is well placed to benefit from rising healthcare spending, increasing insurance penetration, ageing demographics and growing demand for specialised medical care across the country.

Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.